News for Healthier Living

Dana-Farber Investigators Develop Protein Degrader Discovery Platform and Find First-in-Kind Metabolically Activated Molecular Glue Degrader

Investigators at Dana-Farber Cancer Institute have developed a platform for systematically discovering molecular glues that could become protein degradation drug candidates. The research builds on previous Ebert and Fischer lab findings that revealed the potential for molecular glue degraders to benefit patients with cancer.

August 5, 2026


August 12 2026

August 11 2026

August 10 2026

August 7 2026

August 6 2026

August 5 2026

August 4 2026

August 3 2026

August 1 2026

July 31 2026

July 30 2026